Information Provided By:
Fly News Breaks for April 6, 2018
Apr 6, 2018 | 05:26 EDT
KeyBanc analyst Matthew Mishan last night upgraded Halyard Health to Overweight from Sector Weight with a $61 price target. The analyst sees the company's earnings growth accelerating and valuation re-rating following the sale of its Surgical & Infection Prevention unit. After hosting investor meetings with management, Mishan believes accelerated multiyear earnings growth could sustain a higher valuation for Halyard.
News For HYH From the Last 2 Days
There are no results for your query HYH